Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo base editing rescues photoreceptors in a mouse model of retinitis pigmentosa
Jing Su, Kaiqin She, Li Song, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 596-609
Open Access | Times Cited: 22

Showing 22 citing articles:

Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Fang Xu, Caiyan Zheng, Weihui Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
A Future Picture: A Review of Current Generative Adversarial Neural Networks in Vitreoretinal Pathologies and Their Future Potentials
Raheem Remtulla, Adam Samet, Merve Kulbay, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 284-284
Open Access | Times Cited: 1
Inhibiting HMGB1/AGER/NF-κB pathway prevents pro-inflammatory microglia polarization and protect photoreceptors in retinitis pigmentosa
Chaojun Hu, Tao Cui, Zihang Xu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114192-114192
Open Access | Times Cited: 1
AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model
Takao Ukaji, Daisuke Arai, Harumi Tsutsumi, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access | Times Cited: 1
AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa
Yidong Wu, Xiaoling Wan, Dongdong Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Navigating the future of retinitis pigmentosa treatments: A comprehensive analysis of therapeutic approaches in rd10 mice
Hongli Yang, Hui Zhang, Xiaorong Li
Neurobiology of Disease (2024) Vol. 193, pp. 106436-106436
Open Access | Times Cited: 4
Precise Gene Editing Technologies in Retinal Applications
Mehri Ahmadian, Iskalen Cansu Topcu Okan, Gökhan Uyanık, et al.
Advances in experimental medicine and biology (2025), pp. 119-123
Closed Access
ZLN005, a PGC-1α agonist, delays photoreceptor degeneration by enhancing mitochondrial biogenesis in a murine model of retinitis pigmentosa
Chaojun Hu, Chengda Ren, Yan Wu, et al.
Neuropharmacology (2025) Vol. 269, pp. 110361-110361
Open Access
Adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice
Estera Rintz, Betül Çelik, Nidhi Fnu, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102211-102211
Open Access | Times Cited: 3
Optogenetics and Targeted Gene Therapy for Retinal Diseases: Unravelling the Fundamentals, Applications, and Future Perspectives
Merve Kulbay, Nicolas Tuli, Arjin Akdag, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4224-4224
Open Access | Times Cited: 3
Nanomedicine in Ophthalmology: From Bench to Bedside
Binapani Mahaling, Namrata Baruah, Aumreetam Dinabandhu
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7651-7651
Open Access | Times Cited: 2
Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases
Kathleen R. Chirco, Cassandra Martinez, Deepak A. Lamba
Vision Research (2023) Vol. 209, pp. 108257-108257
Open Access | Times Cited: 4
In vivo photoreceptor base editing ameliorates rhodopsin-E150K autosomal-recessive retinitis pigmentosa in mice
Samuel W. Du, Gregory A. Newby, David Salom, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 48
Open Access | Times Cited: 1
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Tiffany Yee, Katherine J. Wert
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12375-12375
Open Access | Times Cited: 6
Vision rescue via chemically engineered endogenous retinal ganglion cells
Rana Muhammad Shoaib, Aregnazan Sandrosyan, Biraj Mahato
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Inefficacy of anti-VEGF therapy reflected in VEGF-mediated photoreceptor degeneration
Xin Xu, Ni Han, Fangkun Zhao, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102176-102176
Open Access
Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retina
Juliette Pulman, Catherine Botto, Hugo Malki, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102349-102349
Open Access
Infantile Nystagmus Syndrome—Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials
Xiujie Gong, Richard W. Hertle
Life (2024) Vol. 14, Iss. 11, pp. 1356-1356
Open Access
NEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice
Zhihui Yang, Xin Cai, Chuyi Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa
Qing Wang, Xiaoshu Xu, Siyu Chen, et al.
Science Advances (2024) Vol. 10, Iss. 51
Closed Access
Saving eyesight, one gene at a time
Rafał Hołubowicz, Krzysztof Palczewski
Trends in Molecular Medicine (2023) Vol. 29, Iss. 7, pp. 484-486
Open Access
Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retina
Catherine Botto, Juliette Pulman, Hugo Malki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top